x
African Health Sciences

    Book Now

    • 256(41)530021
    • info@africanhealthsciences.org
    African Health Sciences
    • info@africanhealthsciences.org
    • Give Feedback
    • Home
    • About Us
    • Staff
    • Focus & Scope
    • For Authors
    • More Links
      • About The Journal
      • Latest Articles
      • Journal Archives
      • Our Events
      • Faq’s
    • Contact Us
    Logo

    Contact Info

    • P. O. Box 7072 Kampala, Uganda
    • +256(41)530021
    • info@africanhealthsciences.org
    • ISSN 1680-6905
    • <!--
    • -->

    14Nov2017

    Nasal carriage of multi-drug resistant Staphylococcus aureus

    by admin,  0 Comments

    Nasal carriage of multi-drug resistant Staphylococcus aureus in healthy inhabitants of Amassoma in Niger delta region of Nigeria

    A Onanuga, TC Temedie

    Abstract

    Background: Nasal Staphylococcus aureus is a major source of community and hospital associated staphylococcal infections. This study determined the prevalence of nasal S. aureus isolates and investigated their antimicrobial resistance profile in healthy volunteers.

    Methods: Nasal specimens of healthy volunteers in Amassoma were cultured and screened for S. aureus using standard microbiological protocols and their antibiotic profile susceptibility was investigated using disc diffusion and agar dilution techniques.

    Results: A total of 40 (33.3%) S. aureus isolates were obtained from 120 nares specimens screened. Twenty three (57.5%) and 17 (42.5%) of the isolates were from university students and villagers respectively. The isolates showed an overall 75% resistance to ampicillin, 52.5% to doxycycline, 47.5% to chloramphenicol, 35% to erythromycin and 32.5% to cotrimoxazole; with 27.5% methicillin resistant. No isolate was resistant to gentamicin while few isolates were resistant to cefuroxime (2.5%), augmentin (5.0%), ciprofloxacin (10.0%), ofloxacin (10.0%) and vancomycin (7.5%). Twenty one (52.5%) of all the isolates were multi-drug resistant, ten (47.6%) of which were methicillin resistant Staphylococcus aureus (MRSA) and only 3 (7.5%) were fully susceptible to all the tested antimicrobial drugs.

    Conclusions: The observation calls for strategies to prevent their spread to more vulnerable populations where the consequences of their infections can be severe.

     

    Related posts:

    Adverse drug reactions in patients

    Knowledge and utilization of malaria control measures

    commercially available quinine sulphate tablets

    Recent Posts

    • Editor’s choice: Tackling infectious diseases, NCDs and sexual reproductivehealth issues as we enter our 24th year of remarkable growth
    • Preconception and contraceptive care for women living with HIV/AIDSattending antiretroviral treatment clinics in Lagos State, Nigeria
    • Effects of SNPs on TNF-α and IL-10 cytokine expression in TB and HIVpatients in the Capricorn district, Limpopo Province, South Africa
    • Prevalence of Schistosomiasis in a neglected community, South western Nigeria at two points in time, spaced three years apart
    • Review of Leishmaniasis in the Middle East and North Africa

    Recent Comments

    No comments to show.

    Archives

    • April 2024
    • May 2019
    • April 2019
    • September 2018
    • August 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017

    Categories

    • 2001 Issues
    • 2002 Issues
    • 2003 Issues
    • 2004 Issues
    • 2005 Issues
    • 2006 Issues
    • 2007 Issues
    • 2008 Issues
    • 2009 Issues
    • 2010 Issues
    • 2011 Issues
    • 2012 Issues
    • 2013 Issues
    • 2014 Issues
    • 2015 Issues
    • 2016 Issues
    • 2017 Issues
    • 2018 Issues
    • 2019 Issues
    • 2024 Issues
    • Articles
    • December issue
    • December Release
    • June Issue
    • June Release
    • March Issue
    • March Issue
    • March Release
    • News
    • number / volume 2
    • number /volume 1
    • number /volume 1
    • number /volume 1 2008
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2 special Issue
    • number 2 special Issue 2
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number/ volume 3 2008
    • number/ volume 4 2008
    • number/volume 1
    • number/volume 1
    • number/volume 2
    • number/volume 2
    • number/volume 2 2008
    • number/volume 3
    • number/volume 3
    • number/volume 3
    • number/volume 4
    • number/volume1
    • September Issue
    • September Release
    • Special Edition
    • special Issue
    • Uncategorized
    • Vol. 24 No. 1 (2024)
    • volume 1
    • volume 1
    • volume 1
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 3
    • volume 3
    • volume 3
    • volume 3
    • volume 4
    • volume 4
    • volume 4
    • volume 4
    • volume1

    Categories

    • 2001 Issues
    • 2002 Issues
    • 2003 Issues
    • 2004 Issues
    • 2005 Issues
    • 2006 Issues
    • 2007 Issues
    • 2008 Issues
    • 2009 Issues
    • 2010 Issues
    • 2011 Issues
    • 2012 Issues
    • 2013 Issues
    • 2014 Issues
    • 2015 Issues
    • 2016 Issues
    • 2017 Issues
    • 2018 Issues
    • 2019 Issues
    • 2024 Issues
    • Articles
    • December issue
    • December Release
    • June Issue
    • June Release
    • March Issue
    • March Issue
    • March Release
    • News
    • number / volume 2
    • number /volume 1
    • number /volume 1
    • number /volume 1 2008
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2 special Issue
    • number 2 special Issue 2
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number/ volume 3 2008
    • number/ volume 4 2008
    • number/volume 1
    • number/volume 1
    • number/volume 2
    • number/volume 2
    • number/volume 2 2008
    • number/volume 3
    • number/volume 3
    • number/volume 3
    • number/volume 4
    • number/volume1
    • September Issue
    • September Release
    • Special Edition
    • special Issue
    • Uncategorized
    • Vol. 24 No. 1 (2024)
    • volume 1
    • volume 1
    • volume 1
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 3
    • volume 3
    • volume 3
    • volume 3
    • volume 4
    • volume 4
    • volume 4
    • volume 4
    • volume1

    Archives

    • April 2024
    • May 2019
    • April 2019
    • September 2018
    • August 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017

    Tags

    Achives Latest News


    ISSN 1680-6905

    • P. O. Box 7072 ,Kampala, Uganda
    • Call Us: 256(41)530021
    • info@africanhealthsciences.org

    Latest Activities

    Usefull Link

    • About AHS
    • Services
    • Focus & Scope
    • Our Articles
    • Contact Us

    Subscribe

    For research updates from African Health Sciences, sign up now!

      African Health Sciences © All Right Reserved